Bisphenol A and estradiol are equipotent in antagonizing cisplatin-induced cytotoxicity in breast cancer cells

被引:41
作者
LaPensee, Elizabeth W. [1 ]
LaPensee, Christopher R. [1 ]
Fox, Sejal [1 ]
Schwemberger, Sandy [2 ]
Afton, Scott [3 ]
Ben-Jonathan, Nira [1 ]
机构
[1] Univ Cincinnati, Dept Canc & Cell Biol, Cincinnati, OH 45267 USA
[2] Univ Cincinnati, Shriners Burns Inst, Cincinnati, OH 45267 USA
[3] Univ Cincinnati, Dept Chem, Cincinnati, OH 45267 USA
关键词
Breast cancer cells; Cisplatin; Bisphenol A; Estradiol; Estrogen receptors; Bcl-2; ESTROGEN-RECEPTOR; ENVIRONMENTAL ESTROGENS; LINE MCF-7; RESISTANCE; BINDING; DEATH; PROLIFERATION; EXPRESSION; APOPTOSIS; CHEMOTHERAPY;
D O I
10.1016/j.canlet.2009.09.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Resistance to chemotherapy is a major problem facing breast cancer patients. Cisplatin, a highly effective DNA-damaging drug, has shown only little success in breast cancer treatment. We are reporting that low nanomolar doses of bisphenol A (BPA) or estradiol antagonize cisplatin cytotoxicity in breast cancer cells, with their effects not mediated via classical estrogen receptors. Although both compounds increase the expression of Bcl-2, a Bcl-2 inhibitor completely blocked the protective effects of BPA while only partially affecting those of estradiol. Blockade of BPA and E2 actions should sensitize ER-negative breast tumors to anti-cancer drugs and allow for the inclusion of cisplatin in treatment regimens. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:167 / 173
页数:7
相关论文
共 36 条
[1]
Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer [J].
Coley, Helen M. .
CANCER TREATMENT REVIEWS, 2008, 34 (04) :378-390
[2]
Bisphenol A induces a profile of tumor aggressiveness in high-risk cells from breast cancer patients [J].
Dairkee, Shanaz H. ;
Seok, Junhee ;
Champion, Stacey ;
Sayeed, Aejaz ;
Mindrinos, Michael ;
Xiao, Wenzhong ;
Davis, Ronald W. ;
Goodson, William H. .
CANCER RESEARCH, 2008, 68 (07) :2076-2080
[3]
Platinum-based chemotherapy in metastatic breast cancer: current status [J].
Decatris, MP ;
Sundar, S ;
O'Byrne, KJ .
CANCER TREATMENT REVIEWS, 2004, 30 (01) :53-81
[4]
Effects of the environmental estrogens bisphenol A, o,p′-DDT, p-tert-octylphenol and coumestrol on apoptosis induction, cell proliferation and the expression of estrogen sensitive molecular parameters in the human breast cancer cell line MCF-7 [J].
Diel, P ;
Olff, S ;
Schmidt, S ;
Michna, H .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2002, 80 (01) :61-70
[5]
Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF [J].
Filardo, EJ ;
Quinn, JA ;
Bland, KI ;
Frackelton, AR .
MOLECULAR ENDOCRINOLOGY, 2000, 14 (10) :1649-1660
[6]
Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells [J].
Huang, Y ;
Ray, S ;
Reed, JC ;
Ibrado, AM ;
Tang, C ;
Nawabi, A ;
Bhalla, K .
BREAST CANCER RESEARCH AND TREATMENT, 1997, 42 (01) :73-81
[7]
LS14: A novel human adipocyte cell line that produces prolactin [J].
Hugo, ER ;
Brandebourg, TD ;
Comstock, CES ;
Gersin, KS ;
Sussman, JJ ;
Ben-Jonathan, N .
ENDOCRINOLOGY, 2006, 147 (01) :306-313
[8]
Bisphenol A at Environmentally Relevant Doses Inhibits Adiponectin Release from Human Adipose Tissue Explants and Adipocytes [J].
Hugo, Eric R. ;
Brandebourg, Terry D. ;
Woo, Jessica G. ;
Loftus, Jean ;
Alexander, J. Wesley ;
Ben-Jonathan, Nira .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2008, 116 (12) :1642-1647
[9]
Death and anti-death: Tumour resistance to apoptosis [J].
Igney, FH ;
Krammer, PH .
NATURE REVIEWS CANCER, 2002, 2 (04) :277-288
[10]
Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer [J].
Jordan, V. Craig ;
Brodie, Angela M. H. .
STEROIDS, 2007, 72 (01) :7-25